GlaxoSmithKline

Aktienkurs
2,206.00
Täglich Wechseln
-7.00 -0.32%
Monatlich
20.65%
Jährlich
51.88%
Q1 Prognose
2,168.74




Ebit Veränderung Datum
AbbVie USD 5.81B 4.36B 2025-12
Alcon AG USD 334M 84M 2025-09
Almirall EUR 43.02M 28.78M 2025-06
Amgen USD 3.96B 464M 2025-12
argenx SE USD 349.97M 61.94M 2025-09
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR -399M 363M 2025-09
Biogen USD 659.6M 157M 2025-09
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Fresenius EUR 574M 14M 2025-09
Fresenius Medical Care EUR 449.94M 18.94M 2025-09
Galapagos EUR -41.67M 15.35M 2025-09
Genmab DKK 432M 900.27M 2025-06
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 3.76B 1.69B 2025-09
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 317M 85M 2024-12
Lonza CHF 673M 54M 2025-06
Merck EUR 1.21B 180M 2025-09
Merck USD 6.24B 1.32B 2025-12
Novartis USD -9.19B 13.87B 2025-06
Novo Nordisk DKK 32.38B 1.7B 2025-12
Orion EUR 328.1M 207.1M 2025-12
Pfizer USD 4.65B 71M 2025-12
Philips EUR 719M 390M 2025-12
Recordati EUR 165.64M 21.71M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Smith & Nephew USD 440M 50M 2025-12
UCB EUR 502M 168M 2024-12


GlaxoSmithKline - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.